Assessment of dried blood micro-sampling methods for oxylipin analysis in newborn blood using UPLC-MS/MS

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Balas, L
  • Durand, T
  • Quintás, G

Grupos

Abstract

Background: Conventional sampling methods for clinical analysis make use of plasma or serum and require large blood volumes, cold storage, and specialized handling. This renders them impractical and invasive, especially when dealing with vulnerable groups of patients and the analysis of low-abundant and unstable compounds such as oxylipins. Dried blood micro-sampling methods are designed for collecting minimally invasive small-volume blood samples (<100 mu L), providing advantages in stability, handling, and storage. The aim of this study is to develop and compare micro-sampling approaches that can be readily implemented in clinical analysis circumventing the barriers of conventional sampling methods. (96) Results: This study assessed the performance of Pre-Cut Dried Blood Spots (PCDBS) and Volumetric Absorptive Micro-Sampling (VAMS (R)) devices for determining oxylipins, using small-volume liquid whole blood sampling as reference. A Liquid Chromatography-tandem Mass Spectrometry method was successfully developed and validated. Both PCDBS and VAMS (R) were prepared using 30 mu L of spiked blood and dried for 2 h before extraction and analysis. Optimal results were achieved by pre-treating devices with antioxidant before sample deposition and avoiding the internal standard to undergo evaporation steps during preparation of micro-sampling devices. Long-term storage effects were assessed over a three-month period, and the micro-sampling devices were tested on umbilical cord blood samples from 35 newborns. For PCDBS and VAMS (R), eight and nine oxylipins, respectively, showed comparable results to those obtained from liquid whole blood samples with mean concentrations ranging between 0.7 and 6.3 nM (140) Significance: This study is the first to analyse oxylipins in umbilical cord blood using VAMS (R) and PCDBS micro-sampling devices, demonstrating their effectiveness for quantification at nM concentrations. It highlights the impact of sample collection, storage, and internal standard handling on lipid profiles. Stability is critical and cold storage (-20 C-degrees) is mandatory. Future research focusing on the standardization of protocols for comparability among laboratories and enhancing sensitivity with improved LC-MS/MS techniques to expand accessible oxylipins are needed. (75)

Copyright © 2025 Elsevier B.V. All rights reserved.

Datos de la publicación

ISSN/ISSNe:
0003-2670, 1873-4324

Analytica Chimica Acta  ELSEVIER

Tipo:
Article
Páginas:
344373-344373
PubMed:
40750190
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
1,105 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 1

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Micro-extraction; Oxylipins; Dried blood spot; Ultra-high performance liquid; chromatography-electrospray ionization tandem mass spectrometry; Inflammation biomarkers; Volumetric absorptive Micro-Sampling (R)

Proyectos y Estudios Clínicos

Short- and long-term impact assessment of inhaled nitric oxide in the treatment of severe hypoxia secondary to persistent pulmonary hypertension in the newborn period (Impacto a corto y largo plazo de la terapia con óxido nítrico inhalado para el tratamiento de hipóxia severa secundaria a la hipertensión pulmonar persistente en el periodo neonatal).

Investigador Principal: JULIA KULIGOWSKI

PI20/00964 . INSTITUTO DE SALUD CARLOS III . 2021

Contrato PFIS 2021. Abel Albiach

Investigador Principal: JULIA KULIGOWSKI

FI21/00193 . INSTITUTO DE SALUD CARLOS III . 2022

Paneles genómicos y metabolómicos para el diagnóstico rápido de la sespsis en recién nacidos menores de 1500 gramos

Investigador Principal: MARÍA CERNADA BADÍA

PI22/00131 . INSTITUTO DE SALUD CARLOS III . 2023

MRR-Vesículas Extracelulares de Leche Materna para la Prevención de la Enterocolotis Necrotizante en el Recién Nacido Prematuro.

Investigador Principal: JULIA KULIGOWSKI

CNS2022-135398 . MINISTERIO DE CIENCIA E INNOVACION . 2023

Contratos Río Hortega 2023. ALEJANDRO PINILLA GONZÁLEZ

Investigador Principal: JUAN SANDOVAL DEL AMOR

CM23/00112 . INSTITUTO DE SALUD CARLOS III . 2024

Administración de Vesículas Extracelulares aislados de Leche Materna Donada como suplemento nutricional para la prevención del desarrollo de Enterocolitis Necrotizante en el recién nacido prematuro – estudio en fase I

Investigador Principal: JULIA KULIGOWSKI

PI23/00202 . INSTITUTO DE SALUD CARLOS III . 2024

Contratos Rio Hortega 2024. TORREJON RODRIGUEZ, LAURA

Investigador Principal: JULIA KULIGOWSKI

CM24/00252 . INSTITUTO DE SALUD CARLOS III . 2025

Cita

Compartir